A non-small cell lung cancer diagnosis is never easy. But you don't have to face it alone. Our team of lung cancer experts has decades of experience helping people navigate this diagnosis. Through treatments tailored to your DNA and nurse navigators that help you overcome challenges, we make sure every moment counts.
Bill and Ralph's lung cancer journey
Married in 2013, Florida residents Bill Cain and Ralph Madden shared an active life together. But when routine screenings revealed both had lung cancer, serendipity brought them 1,000 miles away to Penn Medicine. "From top to bottom, our experience at Penn Medicine was wonderful—and worth every mile in the air and on the road." Read Bill and Ralph's lung cancer story.
Clinical trials
We are studying new combinations of treatments in clinical trials. Clinical trials help improve current treatments and develop new ones. We have clinical trials available for almost every patient who wants to participate.
Why choose Penn Medicine for non-small cell lung cancer care
Our lung cancer team includes nurse navigators with special expertise in non-small cell lung cancer. This training helps them anticipate your needs, getting you the right care and support fast. We also provide:
- Expert care close to home: Our intake system makes sure you receive care from lung cancer experts located close to you. Using your zip code, we make sure you’re able to get the care you need where it's most convenient, including chemotherapy, radiation, and postoperative appointments.
- Experience: As a high-volume cancer center, we see more lung cancer patients than any other hospital in the southeastern Pennsylvania and New Jersey region. We use this experience to provide you with safe, effective care. Research shows that treatment at high-volume centers leads to better outcomes for lung cancer patients.
- Coordinated care: Our lung cancer specialists have regular formal and informal meetings about your care. These meetings mean that the entire team weighs in on treatment decisions. They can also quickly adjust your treatment plan if there's an issue or you would benefit from a different treatment.
- Personalized treatments: Our pulmonary pathologists perform genetic tests on tumors. These tests identify changes in tumor DNA (molecular targets) that make it grow uncontrollably. If you have a molecular target, we can match the right targeted molecular therapy to the specific cancer.
Rated “exceptional” by The National Cancer Institute
Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. Our status as a national leader in cancer care is reflected in our continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 7 such centers in the United States. The ACC is also a member of the National Comprehensive Cancer Network, one of a select few cancer centers in the U.S., that are working to promote equitable access to high-quality, advanced cancer care.